πŸ‡ΊπŸ‡Έ FDA
Patent

US 8106082

Dual-acting antihypertensive agents

granted A61PA61P43/00A61P9/00

Quick answer

US patent 8106082 (Dual-acting antihypertensive agents) held by Theravance, Inc. expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P43/00, A61P9/00, A61P9/04, A61P9/12